Myeloid dendritic cells induce HIV-1 latency in non- proliferating CD4 + T cells IAS WORKSHOP, 16 & 17 JULY 2010.

Slides:



Advertisements
Similar presentations
Purging the HIV-1 Reservoir Through the Disruption of the PD-1 Pathway
Advertisements

Measuring the latent HIV Reservoir
2014 “Towards an HIV Cure” symposium Melbourne Following in vitro culture with myeloid dendritic cells, negative regulators of T cell activation are expressed.
Unique integration patterns in an in vitro model of HIV-1 latency. Suha M. Saleh, Dimitrios Vatakis, Andrew Harman, Anthony Cunningham, Paul U. Cameron,
Contribution of the immune system to HIV persistence Sharon R Lewin Director, Infectious Disease Unit, Alfred Hospital Professor, Department of Medicine,
Myeloid dendritic cells and HIV latency in resting T-cells Nitasha A Kumar, Vanessa A Evans, Suha Saleh, Candida de Fonseca Pereira, Paula Ellenberg, Paul.
Alternative RNA splicing in latently infected T cells generates chimeric cellular:HIV mRNAs with the potential to generate Tat and reactivate infection.
2014 “Towards an HIV Cure” symposium Melbourne A novel assay that precisely measures the size of the latent HIV reservoir reveals that ART-nai ̈ ve individuals.
Measuring the latent HIV Reservoir
2014 “Towards an HIV Cure” symposium Melbourne The Immune Checkpoints PD-1, LAG-3 and TIGIT are Biomarkers of HIV Infected Cells During ART and Identify.
Cell- and Tissue-based Measures of Viral Persistence Are Associated with Immune Activation and PD-1-Expressing CD4+ T cells H Hatano 1, V Jain 1, PW Hunt.
The role of PI3K signaling pathways in HIV-1 infection of resting CD4+T-cells Suha Saleh, Paul Cameron, Georgina Sallmann, Anthony Jaworowski, and Sharon.
Latent infection and cellular reservoirs
Tumor genetics Minna Thullberg
2014 “Towards an HIV Cure” symposium Melbourne
Myeloid cells matter Conclusions. Glut1+ CD14++ CD16+ Associated with inflammatory markers HIV Immune activation HIV-related diseases Joshua Anzigen:
Novel Approaches: Treatment and HIV Pathogenesis L. Trautmann, Ph.D. VGTI Florida.
HIV Cellular Pathogenesis III
Anti-HIV Antibody Responses Reflect the Quantifiable HIV Reservoir Size Sulggi Lee, M.D., Ph.D. Assistant Professor of Medicine University of California,
Non-Infectious Papilloma virus–like Particles (VLPs) inhibit HIV-1 replication: Implications for immune control of HIV-1 replication by IL-27. Laboratory.
A new molecular mechanism for HIV-1 latency HIV latency in primary T cells: natural activation/purging by DCs Ben Berkhout Academic Medical Center University.
Effect of 24 Week Intensification with a CCR5-Antagonist on the Decay of the HIV-1 Latent Reservoir IAS HIV RESERVOIRS WORKSHOP, 16 & 17 JULY 2010, VIENNA.
Primary HIV-1 Infection Pathogenesis, Diagnosis, and Treatment Summary of Evidence Martin Markowitz M.D. Clinical Director and Staff Investigator Aaron.
HIV Cellular Pathogenesis III Benhur Lee, M.D.. Adult v. infant (IgG v. IgA) CTL response (MHC tetramers) p24 antigenimia Ab response Viral load.
CDER Meeting: Surrogate Markers of Immunity Presenter: Judith A. Britz, Ph.D. October 16, 2000.
Peripheral T follicular Helper Cells (pTfh)
Mechanisms of HIV Latency
ImmunoPathogenesis of HIV Disease Overview of HIV Epidemic Basic biology of HIV-1 Stages of HIV Disease Viral and Cellular Dynamics after HAART HIV Therapy.
Title Box. “Towards an HIV Cure”: Presentation Outline -Why do we need a cure? -Is a cure feasible and what type of cure can we reach? -Why does HAART.
___________DEFENSES of the HOST: THE IMMUNE RESPONSE
IAS Members Meeting July 19th 2011 Achievements and learning over the past 30 years: what do we need next? Françoise BARRÉ-SINOUSSI Regulation of Retroviral.
HIV: Science, Sex and Society. Lecture 1. Mechanisms of viral persistence in the face of antiviral therapy. Mario Stevenson, Ph.D Department of Medicine.
BIT225 Reduces the Intracellular HIV-1 Burden Within Monocyte Derived Dendritic Cells, Resulting in Reduced Transfer of Virus to more Permissive CD4 +
PROFESSIONAL ANTIGEN PRESENTING CELLS
The Future of HIV/AIDS: The Road to a Cure. How HIV persists during therapy?  Ongoing viral replication occurs in subjects on suppressive HAART (TW Chun,
Robert F. Siliciano, MD, PhD Professor of Medicine The Johns Hopkins University School of Medicine Baltimore, Maryland Update on HIV Cure Research FORMATTED:
Immune reconstitution Anjie Zhen, PhD
2014 “Towards an HIV Cure” symposium Melbourne An Overview of HIV Cure Research in 2014 Diana Finzi, Ph.D. Director, Basic Science Program Division of.
Relationship Between STAT3 Inhibition and the Presence of p53 on Cyclin D1 Gene Expression in Human Breast Cancer Cell Lines Introduction STAT3 and p53.
The Problem of Cancer. What are cancer cells ? Cancerous growth involves unrestrained proliferation (malignancy) and spread (metastasis). Caused by: mutations.
During HIV infection, CD4 T cells in lymphoid tissues initiate a highly inflammatory form of cell death that helps cripple the immune system.
HIV-infected patients, and have proliferative defects
State of HIV Cure Research
Washington State University
Mouse Double Minute 2 (MDM2)
PBMCs from patients with chronic myeloid leukemia treated with different tyrosine kinase inhibitors show variable susceptibility to HIV-1 infection: searching.
HIV Cure: Current Status and Future Perspectives
Thymocyte development summary
Volume 36, Issue 3, Pages (March 2012)
HEATHER Feedback Meeting
Immunological memory Topics Immune regulation  T cells
HIV-1 Latency by Transition
The block-and-lock approach
Differentiation and Functions of CD8+ Effector T Cells
Volume 9, Issue 1, Pages (January 1999)
Volume 21, Issue 12, Pages (December 2017)
Why we should ‘shock and kill’
Volume 15, Issue 4, Pages (October 2001)
Nat. Rev. Nephrol. doi: /nrneph
The Expression Pattern of Epstein-Barr Virus Latent Genes In Vivo Is Dependent upon the Differentiation Stage of the Infected B Cell  Gregory J Babcock,
EBV infection in healthy carriers.
Volume 13, Issue 2, Pages (February 2006)
Volume 36, Issue 3, Pages (March 2012)
Lec.10 Immune response كلية المأمون الجامعة\قسم تقنيات التحليلات المرضية مادةالمناعة-النظري/المرحلةالثالثة م.م.رشد اياد عبدالحميد.
Greg J. Towers, Mahdad Noursadeghi  Cell Host & Microbe 
Steven Yukl UCSF and San Francisco VA
Fig. 3. The effect of VRC01 infusion on virus load in plasma and blood CD4 T cells during ART. The effect of VRC01 infusion on virus load in plasma and.
Volume 15, Issue 4, Pages (October 2001)
Latent human cytomegalovirus enhances HIV-1 infection in CD34+ progenitor cells by Allen Ka Loon Cheung, Yiru Huang, Hau Yee Kwok, Min Chen, and Zhiwei.
Early events following Orientia tsutsugamushi infection.
Presentation transcript:

Myeloid dendritic cells induce HIV-1 latency in non- proliferating CD4 + T cells IAS WORKSHOP, 16 & 17 JULY 2010

Resting CD4 + T cells: a cellular reservoir of latent HIV-1  Memory – considered major reservoir  Observed early in infection  Long half life ~ months  Resistant to  Antiretrovirals  Host immune recognition Finzi et al., Science 1997; 278:1295; Wong et al., Science 1997; 278:1291; Chun et al., PNAS 1997; 94:13193; Siliciano et al., Nat Med 2003; 9:727; Ramratnam et al., JAIDS 2004; 35:33 IAS HIV RESERVOIRS WORKSHOP, 16 & 17 JULY 2010, VIENNA

Resting CD4 + T cell latency Resting CD4 + T cell Blood Lymphoid blocks Possible role for cellular secretions and/or cell-cell interactions within lymphoid tissues Pre-integration Post-integration OR Eckstein et al., Immunity 2001, 15: 671; Kreisberg et al., J Exp Med 2006, 203:865; Saleh et al., Blood 2007, 110:416

IAS HIV RESERVOIRS WORKSHOP, 16 & 17 JULY 2010, VIENNA High frequency of integrated HIV-1 with low level of productive infection in resting cells incubated with CCL19 Saleh et al., Blood 2007; 110: RT CPM/ul Days after infection Unconditioned PHA/IL-2 CCL19

IAS HIV RESERVOIRS WORKSHOP, 16 & 17 JULY 2010, VIENNA Hypothesis Establishment of latency occurs as a result of signalling by DC during the recirculation of CD4 + T cells through lymphoid tissue DC are found within T-zones of lymphoid tissues

IAS HIV RESERVOIRS WORKSHOP, 16 & 17 JULY 2010, VIENNA In vitro model R5 EGFP-HIV-1 24 hrs SNARF - 10 Resting CD4 + T cells +/- SEB 10ng/mL DC added 1:10 Resting CD4 + T cells + DC +/- SEB 10ng/mL

IAS HIV RESERVOIRS WORKSHOP, 16 & 17 JULY 2010, VIENNA R5 EGFP-HIV-1 (2h pulse) Non-proliferating SNARF hi Not productively infected EGFP - EGFP SNARF PHA 5 Days SNARF hi EGFP - CD4 + T cells Amplification in PBMC SNARF EGFP 5 Days Detection of replication competent latent infection PBMC EGFP + feeder PBMC a surrogate for latently infected cells

IAS HIV RESERVOIRS WORKSHOP, 16 & 17 JULY 2010, VIENNA SNARF hi EGFP - CD4 + T cells 05 Days post sort Unstimulated PHA-PBMC DC induce latent infection of SNARF hi EGFP - CD4 + T cells Unstimulated Amplification of HIV-1 from latently NOT productively infected cells SEB Stimulated p<0.05

IAS HIV RESERVOIRS WORKSHOP, 16 & 17 JULY 2010, VIENNA Activation state of the SNARF hi EGFP - CD4 + T cells Unstimulated Sorted SNARF hi EGFP - cells were non-proliferating CD4 + T cells Percent positive cells CD69 HLA-DR Ki67 SEB Stimulated

IAS HIV RESERVOIRS WORKSHOP, 16 & 17 JULY 2010, VIENNA 24 hrs EGFP HIV-1 Resting CD4 + T DC Soluble factors play a role in DC-induced latency Is DC-T cell contact required? EGFP + cells /10 4 cells (Latently infected cells) p=0.03

IAS HIV RESERVOIRS WORKSHOP, 16 & 17 JULY 2010, VIENNA Blocking CD18 inhibits DC-T cell adhesion Cell-cell contact AND soluble factors are required for maximal DC-induced latency

IAS HIV RESERVOIRS WORKSHOP, 16 & 17 JULY 2010, VIENNA 24 hrs Resting CD4 + T DC EGFP HIV-1 Latency inducing soluble factors are secreted by DC as a result of HIV-1 stimulation Do DC condition resting CD4 + T cells towards latency without HIV-1 exposure?

IAS HIV RESERVOIRS WORKSHOP, 16 & 17 JULY 2010, VIENNA Do pDC or mDC induce latency? Myeloid DC induce HIV-1 latency in non-proliferating CD4 + T cells Days 0 CD4 + T± HIV-1 EGFP 5 + PHA-PBMC SNARF hi EGFP - CD4 + T cells SNARF-resting CD4 + T cells + pDC + mDC 5 Days Unstimulated CD4 + T CD4 + T CD4 + T (post pDC) (post mDC) EGFP + cells /10 4 cells (Latently infected cells) p=0.02 p=0.01 SEB Stimulated CD4 + T CD4 + T CD4 + T (post pDC) (post mDC) p=0.02

IAS HIV RESERVOIRS WORKSHOP, 16 & 17 JULY 2010, VIENNA mDC induce post-integration latency in non-proliferating CD4 + T cells SNARF hi EGFP - CD4 + T cells Integrated HIV-1 DNA (Alu-LTR nested PCR) Unstimulated Alu-LTR copies /10 6 cells CD4 + T pDC: CD4 + T mDC: CD4 + T SEB Stimulated CD4 + T pDC: CD4 + T mDC: CD4 + T CD4 + T CD4 + T CD4 + T (post pDC) (post mDC ) CD4 + T CD4 + T CD4 + T (post pDC) (post mDC )

IAS HIV RESERVOIRS WORKSHOP, 16 & 17 JULY 2010, VIENNA Summary  mDC induce post-integration latency  Mediated by  DC-T cell contact  Soluble factors (HIV-1 exposure)  Partial activation?  Enhanced by SEB

IAS HIV RESERVOIRS WORKSHOP, 16 & 17 JULY 2010, VIENNA Days post infection 0 ± DC HIV-1 EGFP MOI 1 5 Non-proliferating (SNARF hi )Not productively infected (EGFP - ) Lysed for microarrays MOCK Gene profiles of DC-induced latently infected CD4 + T cells

IAS HIV RESERVOIRS WORKSHOP, 16 & 17 JULY 2010, VIENNA MockLatent p<0.05 Non-proliferating CD4 + T cells co-cultured with DC Genes

IAS HIV RESERVOIRS WORKSHOP, 16 & 17 JULY 2010, VIENNA 65 genes involved in cell cycle  28 genes  Arrest in cell division (24)  Delay in cell division (9)  Arrest in cell cycle progression (13)  Arrest G0/G1 phase transition (2) GADD45A – growth arrest IFI16 – growth arrest 11 Upregulated CHKA – G0/G1 transition CDC20/AURKB – mitosis IL-16/BIRC5 – cell cycle 17 Downregulated Latently infected non-proliferating CD4 + T cells

IAS HIV RESERVOIRS WORKSHOP, 16 & 17 JULY 2010, VIENNA  TRIM22  OAS1  TXNRD1 Upregulation Genes that inhibit HIV-1  IKBE  ITGAL  PRKCA  TNFRSF14 Downregulation Genes involved in NFkB activation Latently infected CD4 + T cells

IAS HIV RESERVOIRS WORKSHOP, 16 & 17 JULY 2010, VIENNA  Suboptimal activation – ↑CD69  Enhanced integration  Productive infection prevented:  Blocks in HIV-1 transcription  Blocks in cell proliferation mDC-induced post-integration latency in non-proliferating CD4 + T cells In vitro model to study the establishment and/or reactivation of latency in primary resting CD4 + T cells A mechanism for the establishment of latency in vivo within lymphoid tissues

Acknowledgements MONASH UNIVERSITY Sharon Lewin Paul Cameron Suha Saleh Geza Paukovics UNIVERSITY OF MONTREAL Rafick-Pierre Sekaly Elias Haddad Nadia Kettaf Jean-Philipe Goulet UNIVERSITY OF MELBOURNE Damian Purcell IAS HIV RESERVOIRS WORKSHOP, 16 & 17 JULY 2010, VIENNA